AlphaCrest Capital Management’s Health Catalyst HCAT Stock Holding History

AlphaCrest Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$224K	Sell
2022 Q2	$2.08M	Buy
2022 Q1	$1.62M	Sell
2021 Q4	$2.78M	Buy
2021 Q3	$1.63M	Sell
2021 Q2	$2.28M	Buy
2021 Q1	$318K	Sell
2020 Q4	$770K	Buy